Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maria Caterina Micó"'
Autor:
Massimo Martino, Gaetana Porto, Giorgia Policastro, Caterina Alati, Barbara Loteta, Maria Caterina Micó, Clizia Argiró, Maria Altomonte, Tiziana Moscato, Demetrio Labate, Vincenzo Dattola, Carmelo Massimiliano Rao, Francesca Cogliandro, Filippo Antonio Canale, Virginia Naso, Gianfranco Filippelli, Antonino Iaria, Martina Pitea
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/4c7e9bb392734df6bc0b4849bdd35e5f
Autor:
Gianluca Cavallaro, Anna Grassi, Chiara Pavoni, Maria Caterina Micò, Alessandro Busca, Irene Maria Cavattoni, Stella Santarone, Carlo Borghero, Attilio Olivieri, Giuseppe Milone, Patrizia Chiusolo, Pellegrino Musto, Riccardo Saccardi, Francesca Patriarca, Fabrizio Pane, Giorgia Saporiti, Paolo Rivela, Elisabetta Terruzzi, Raffaella Cerretti, Giuseppe Marotta, Angelo Michele Carella, Arnon Nagler, Domenico Russo, Paolo Corradini, Paolo Bernasconi, Anna Paola Iori, Luca Castagna, Nicola Mordini, Elena Oldani, Carmen Di Grazia, Andrea Bacigalupo, Alessandro Rambaldi
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract We report the long-term results of a randomized trial (GITMO, AML-R2), comparing 1:1 the combination of busulfan and cyclophosphamide (BuCy2, n = 125) and the combination of busulfan and fludarabine (BuFlu, n = 127) as conditioning regimen i
Externí odkaz:
https://doaj.org/article/3d88f978b9834d21ac204c0a720eb318
Autor:
Barbara Loteta, Annalisa Pitino, Martina Pitea, Caterina Alati, Giovanni Tripepi, Maria Caterina Mico', Maria Pellicano', Francesca Cogliandro, Gaetana Porto, Giorgia Policastro, Giovanna Utano, Ilaria Maria Delfino, Annalisa Sgarlata, Anna Scopelliti, Aurora Idato, Giovanni Laenza, Maria Altomonte, Graziella D'Arrigo, Mercedes Gori, Massimo Martino
Publikováno v:
Frontiers in Hematology, Vol 3 (2024)
ObjectivesTo evaluate the efficacy of biosimilar (BIO) pegfilgrastim (PEG) in lymphoma patients after autologous stem cell transplantation (ASCT).Methods86 consecutive lymphoma patients who received BIO/PEG after ASCT were assessed. The primary endpo
Externí odkaz:
https://doaj.org/article/75271c232043486098d7ca8015c0fcd2
Autor:
Giuliana Rizzuto, Matteo Leoncin, Silvia Imbergamo, Daniela Taurino, Maria Caterina Mico, Manuela Tosi, Anna Michelato, Ksenija Buklijas, Orietta Spinelli, Federico Lussana, Federica Lessi, Marco Pizzi, Laura Bonaldi, Gianni Binotto, Alessandro Rambaldi, Carmela Gurrieri
Publikováno v:
Clinical Case Reports, Vol 10, Iss 1, Pp n/a-n/a (2022)
Abstract The translocation t(8;9)(p22;p24) results in the production of a chimeric PCM1‐JAK2 fusion protein leading to the constitutive activation of the Janus Kinase 2 that renders this disease potentially sensitive to ruxolitinib. Here, we report
Externí odkaz:
https://doaj.org/article/d50e9d6c5d4847dcb99c79bb273a8c62